Primum non nocere: Active surveillance for clinical stage i testicular cancer

Journal of Clinical Oncology

Volumn 33, Issue 1, 2015, Pages 9-12

  Vaughn, David J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NODULE; LYMPH VESSEL METASTASIS; LYMPHADENOPATHY; MALE; ORCHIECTOMY; PELVIS RADIOGRAPHY; RETE TESTIS; SCROTAL PAIN; SEMINOMA; TESTICULAR ENLARGEMENT; TESTIS CANCER; TESTIS NONSEMINOMA CANCER; THORAX RADIOGRAPHY; TUMOR INVASION; TUNICA VAGINALIS; ULTRASOUND; YOUNG ADULT; ADOLESCENT; BLOOD; LITERATURE; METABOLISM; PRACTICE GUIDELINE; TESTICULAR NEOPLASMS;

ADOLESCENT; ALPHA-FETOPROTEINS; HUMANS; MALE; NEOPLASM STAGING; ORCHIECTOMY; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 84920574894     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.2247     Document Type: Article

References (22)

1. National Cancer Institute, Surveillance, Epidemiology, and End Results Program (SEER): SEER Stat Fact Sheets: Testis Cancer. http://seer.cancer.gov/statfacts/html/testis.html
2. Kollmannsberger C, Tanstad T, Bedard P.L., et al.: Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol 33:51-57, 2015
3. Jeldres C, Nichols CR, Pham K, et al.: United States trends in patterns of care in clinical stage I testic-ular cancer: Results from the National Cancer Database (1998-2011). J Clin Oncol 32, 2014 (suppl 5s; abstr 369)
4. Zagers GK, Ballo MT, Lee A.K., et al.: Mortality after cure of testicular seminoma. J Clin Oncol 22:640-647, 2004
5. Travis LB, Fosså SD, Schonfeld SJ, et al.: Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 97:1354-1365, 2005
6. Powles T, Robinson D, Shamash J., et al.: The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 19:443-447, 2008
7. Oliver RT, Mason MD, Mead G.M., et al.: Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomized trial. Lancet 366:293-300, 2005
8. Oliver RT, Mead GM, Rustin G.J., et al.: Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19/ EORTC 30982 study (ISRCTN27163214). J Clin Oncol 29:957-962, 2011
9. Vergouwe Y, Steyerberg EW, Eijkemans M.J., et al.: Predictors of occult metastasis in clinical stage I nonseminoma: A systematic review. J Clin Oncol 21:4092-4099, 2003
10. Huddart RA, Norman A, Shahidi M., et al.: Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:1513-1523, 2003
11. Albers P, Siener R, Krege S., et al.: Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 26:2966-2972, 2008
12. Kollmannsberger C, Moore C, Chi K.N., et al.: Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: Diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol 21:1296-1301, 2010
13. Tandstad T, Dahl O, Cohn-Cedermark G, et al.: Risk-adapted treatment in clinical stage I nonseminoma-tous germ cell testicular cancer: The SWENOTECA management program. J Clin Oncol 27:2122-2128, 2009
14. de Wit R, Bosl GJ: Optimal management of clinical stage I testis cancer: One size does not fit all. J Clin Oncol 31:3477-3479, 2013
15. National Comprehensive Cancer Network: NCCN guidelines: Testicular cancer. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#site
16. Vesprini D, Chung P, Tolan S., et al.: Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 118:5245-5250, 2012
17. Gilligan TD, Seidenfeld J, Basch E.M., et al.: American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol 28:3388-3404, 2010
18. Tolan S, Vesprini D, Jewett M.A., et al.: No role for routine chest radiography in stage I seminoma surveillance. Eur Urol 57:474-479, 2011
19. Ehrlich Y, Beck SD, Foster R.S., et al.: Serum tumor markers in testicular cancer. Urol Oncol 31: 17-23, 2013
20. van Walraven C, Fergusson D, Earle C., et al.: Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicu-lar cancer. J Clin Oncol 20:2883-2888, 2011
21. O'Malley ME, Chung P, Haider M., et al.: Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance. Eur Radiol 20: 1624-1630, 2010
22. Sohaib SA, Koh DM, Barbachano Y, et al.: Prospective assessment of MRI for imaging retro-peritoneal metastases from testicular germ cell tumours. Clin Radiol 64:362-367, 2009